Editorial: Prognostic Research and Precision Oncology in Upper Tract Urothelial Carcinoma

Zai-Lin Sheu; Nirmish Singla; Chung-Hsin Chen; Jer-Tsong Hsieh; Hsin-Chih Yeh

doi:10.3389/fonc.2022.956352

Editorial: Prognostic Research and Precision Oncology in Upper Tract Urothelial Carcinoma

Front Oncol. 2022 Jun 21:12:956352. doi: 10.3389/fonc.2022.956352. eCollection 2022.

Authors

Zai-Lin Sheu¹, Nirmish Singla², Chung-Hsin Chen³, Jer-Tsong Hsieh⁴, Hsin-Chih Yeh^{5

6

7

8}

Affiliations

¹ School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
² Brady Urological Institute, School of Medicine, Johns Hopkins Medicine, Baltimore, MD, United States.
³ Department of Urology, National Taiwan University Hospital, Taipei, Taiwan.
⁴ Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, United States.
⁵ Department of Urology, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung, Taiwan.
⁶ Department of Urology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
⁷ Department of Urology, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
⁸ Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.

No abstract available

Keywords: 7-(deoxyadenosin-N6-yl) aristolactam I; acidic urine; hematuria; pathology review; precision oncology; pyruvate dehydrogenase kinase-3; symptomatic hydronephrosis; upper tract urothelial carcinoma.

Publication types

Editorial